Patents by Inventor Andrew E. Lewis

Andrew E. Lewis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Drug Delivery From Stents
    Publication number: 20130309289
    Abstract: An intravascular stent has a coating comprising a crosslinked amphiphilic polymer and a sparingly water soluble matrix metalloproteinase inhibitor (MMPI). Preferably the polymer is formed from 2-methacryloyloxy-2?-ethyltrimethylammonium phosphate inner salt, C4-18 alkyl methacrylate and reactive and/or crosslinking monomer and the MMPI is a hydroxamic acid, more preferably batimastat. Preclinical and clinical results are reported, showing good luminal areas and reduced intimal thickening.
    Type: Application
    Filed: May 20, 2013
    Publication date: November 21, 2013
    Applicant: Abbott Laboratories
    Inventors: Andrew E. Lewis, Peter W. Stratford, Michael J. Driver